Erik Supratik Mittra MD PhD

Nuclear Medicine•Portland, OR

Associate Professor of Diagnostic Radiology; Chief, Nuclear Medicine & Molecular Imaging; Oregon Health & Science University

Join to View Full Profile

3181 SW Sam Jackson Park RdPortland, OR 97239
Phone+1 503-418-0990
Fax+1 503-494-4982

Education & Training

Stanford Health CareFellowship, PET/CT Clinical Oncology, 2008 - 2009
Stanford Health Care-Sponsored Stanford UniversityResidency, Nuclear Medicine, 2006 - 2008
Stony Brook Medicine/University HospitalInternship, Internal Medicine, 2005 - 2006
Stony Brook University Health Sciences Center School of MedicineClass of 2005

Certifications & Licensure

OR State Medical License 2017 - 2025
CA State Medical License 2007 - 2018
American Board of Nuclear Medicine Nuclear Medicine

Clinical Trials

4D-CT-based Ventilation Imaging for Adaptive Functional Guidance in Radiotherapy Start of enrollment: 2009 Dec 01
Terminated
Early Phase 1
A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours Start of enrollment: 2012 Sep 06
Completed
Phase 3
18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas Start of enrollment: 2014 Dec 01
Terminated
Not Applicable
PET Imaging of Intracranial Cancers With 18F-FSPG Start of enrollment: 2014 Nov 01
Terminated
Phase 1
NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer Start of enrollment: 2015 Apr 01
Terminated
Phase 1
68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer Start of enrollment: 2015 Apr 01
Completed
Phase 2
68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment Start of enrollment: 2017 May 20
Completed
Phase 2, Phase 3
PET/MRI Evaluation of Cardiac Amyloid Start of enrollment: 2016 May 26
Completed
Early Phase 1
Use of PET/MR Imaging in Chronic Pain Start of enrollment: 2014 Nov 24
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

1 citations
Dosimetry of [Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial.
Lisa Bodei, Marta Cremonesi, Mahila Ferrari, Erik S Mittra, Harshad R Kulkarni
Journal of Nuclear Medicine. 2025-03-03
Navigating Radiation Safety After Radiopharmaceutical Therapies: Proposed Workflow and Essential Guidelines for Nonspecialists.
Anna Mench, Celeste Winters, Erik Mittra, Laszlo Szidonya, Catherine Hess
Journal of Nuclear Medicine. 2025-02-27
1 citations
A model of lymphocryptovirus-associated post-transplant lymphoproliferative disorder in immunosuppressed Mauritian cynomolgus macaques.
Helen L Wu, Whitney C Weber, Courtney M Waytashek, Carla D Boyle, Jason S Reed
Plos Pathogens. 2024-11-01

Authored Content

It May Be Time to Stop Classifying Theranostics as a Radiology SubspecialtyJuly 2019
It May Be Time to Stop Classifying Theranostics as a Radiology SubspecialtyJuly 2019
Navigating the Evolving Landscape of Neuroendocrine TumorsJanuary 2019

Press Mentions

Clinical Challenges: Nuclear Medicine and Neuroendocrine TumorsApril 30th, 2020
Clinical Challenges: Nuclear Medicine and Biochemically Recurrent Prostate CancerApril 23rd, 2020
PET/MRI Evaluation of Cardiac AmyloidApril 13th, 2017
Join now to see all

Committees

Member, OHSU MD/PhD Committee 2018 - Present
Chair, SNMMI Committee on Chapters 2018 - Present
Board Member, SNMMI Outreach Committee 2016 - Present
Board Member, SNMMI Therapy Center of Excellence 2016 - Present
Chair, SNMMI Targeted Radiotherapy Working Group 2016 - Present
Board Member, SNMMI PET Center of Excellence 2014 - Present
Chair, ISCD CME Committee 2017 - 2019

Professional Memberships

Society of Nuclear Medicine & Molecular Imaging
Member
International Society of Clinical Densitometry
Member

Other Languages

Bengali